Explore more publications!
Vanuatu Health Times
Submit Press Release

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 29, 2025

Curia 发布 2024 年度环境、社会和治理 (ESG) 报告
October 29, 2025

Curia 发布 2024 年度环境、社会和治理 (ESG) 报告

Indeterminate GlobeNewswire
Curia เผยแพร่รายงานด้านสิ่งแวดล้อม สังคม และธรรมาภิบาล (ESG) ประจำปี 2024
October 29, 2025

Curia เผยแพร่รายงานด้านสิ่งแวดล้อม สังคม และธรรมาภิบาล (ESG) ประจำปี 2024

Indeterminate GlobeNewswire
Curia 發表 2024 年環境、社會與管治（ESG）報告
October 29, 2025

Curia 發表 2024 年環境、社會與管治（ESG）報告

Indeterminate GlobeNewswire
Neutrolis Presented First-in-Human Proof-of-Concept Data Validating DNASE1L3-Mediated Neutrophil Extracellular Trap (NET) Clearance as a Therapeutic Approach in Autoimmunity at American College of Rheumatology Convergence 2025
October 29, 2025

Neutrolis Presented First-in-Human Proof-of-Concept Data Validating DNASE1L3-Mediated Neutrophil Extracellular Trap (NET) Clearance as a Therapeutic Approach in Autoimmunity at American College of Rheumatology Convergence 2025

Indeterminate GlobeNewswire
Cost Increases Will Make Insurance Unaffordable for Many People with Chronic Health Conditions Like Asthma
October 29, 2025

Cost Increases Will Make Insurance Unaffordable for Many People with Chronic Health Conditions Like Asthma

Indeterminate GlobeNewswire
Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data
October 29, 2025

Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data

Indeterminate GlobeNewswire
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
October 29, 2025

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

Indeterminate GlobeNewswire
Plum Tree Launches New Chronic Illness Therapy Program
October 29, 2025

Plum Tree Launches New Chronic Illness Therapy Program

Indeterminate GlobeNewswire
MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency
October 29, 2025

MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency

Indeterminate GlobeNewswire
Enabli Health Launches to Help Healthcare Providers Solve Growing Allied Health Shortages
October 29, 2025

Enabli Health Launches to Help Healthcare Providers Solve Growing Allied Health Shortages

Indeterminate GlobeNewswire
OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category
October 29, 2025

OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Indeterminate GlobeNewswire
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
October 29, 2025

FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

Indeterminate GlobeNewswire
Truveta research published in Radiology Advances introduces new AI model to estimate body composition from chest radiographs
October 29, 2025

Truveta research published in Radiology Advances introduces new AI model to estimate body composition from chest radiographs

Indeterminate GlobeNewswire
Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy
October 29, 2025

Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy

Indeterminate GlobeNewswire
Betterguards Launches The BetterGuard Lite, a Powerful New Ankle Protection System with Breakthrough Design
October 29, 2025

Betterguards Launches The BetterGuard Lite, a Powerful New Ankle Protection System with Breakthrough Design

Indeterminate GlobeNewswire
Targeted Biologics Expand in Early-Line gMG Treatment as New Entrants Prepare to Challenge Established Leaders
October 29, 2025

Targeted Biologics Expand in Early-Line gMG Treatment as New Entrants Prepare to Challenge Established Leaders

Indeterminate GlobeNewswire
de Beaumont Foundation Funds First-of-Its-Kind AI Platform to Strengthen Health Communication and Combat False Narratives
October 29, 2025

de Beaumont Foundation Funds First-of-Its-Kind AI Platform to Strengthen Health Communication and Combat False Narratives

Indeterminate GlobeNewswire
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug
October 29, 2025

Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug

Indeterminate GlobeNewswire
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
October 29, 2025

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 29, 2025

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions